Tonghua Golden-Horse Pharmaceutical Industry Co Ltd
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd., together with its subsidiaries, engages in the research, development, manufacture, and sale of pharmaceutical products in China. Its products covers anti-tumor, microbial, cardiovascular, heat-clearing and detoxification, digestive system, skeletal muscle system, gynecological system, nervous system, and other fields. The company also provides… Read more
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766) - Total Assets
Latest total assets as of September 2025: CN¥4.53 Billion CNY
Based on the latest financial reports, Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766) holds total assets worth CN¥4.53 Billion CNY as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd - Total Assets Trend (1994–2024)
This chart illustrates how Tonghua Golden-Horse Pharmaceutical Industry Co Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd's total assets of CN¥4.53 Billion consist of 27.0% current assets and 73.0% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 6.1% |
| Accounts Receivable | CN¥541.60 Million | 12.1% |
| Inventory | CN¥382.19 Million | 8.5% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥374.35 Million | 8.4% |
| Goodwill | CN¥1.90 Million | 0.0% |
Asset Composition Trend (1994–2024)
This chart illustrates how Tonghua Golden-Horse Pharmaceutical Industry Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Tonghua Golden-Horse Pharmaceutical Industry Co Ltd's current assets represent 27.0% of total assets in 2024, a decrease from 63.2% in 1994.
- Cash Position: Cash and equivalents constituted 6.1% of total assets in 2024, down from 36.4% in 1994.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 8.0% of total assets, an increase from 1.0% in 1994.
- Asset Diversification: The largest asset category is accounts receivable at 12.1% of total assets.
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd Competitors by Total Assets
Key competitors of Tonghua Golden-Horse Pharmaceutical Industry Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Tonghua Golden-Horse Pharmaceutical Industry Co Ltd generates 0.29x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Tonghua Golden-Horse Pharmaceutical Industry Co Ltd generates $ 1.26 in net profit.
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.25 | 1.92 | 2.00 |
| Quick Ratio | 1.57 | 1.28 | 1.43 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥703.24 Million | CN¥ 578.76 Million | CN¥ 765.54 Million |
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd - Advanced Valuation Insights
This section examines the relationship between Tonghua Golden-Horse Pharmaceutical Industry Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 8.92 |
| Latest Market Cap to Assets Ratio | 0.45 |
| Asset Growth Rate (YoY) | -0.8% |
| Total Assets | CN¥4.48 Billion |
| Market Capitalization | $2.01 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Tonghua Golden-Horse Pharmaceutical Industry Co Ltd's assets below their book value (0.45 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Tonghua Golden-Horse Pharmaceutical Industry Co Ltd's assets decreased by 0.8% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (1994–2024)
The table below shows the annual total assets of Tonghua Golden-Horse Pharmaceutical Industry Co Ltd from 1994 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥4.48 Billion | -0.79% |
| 2023-12-31 | CN¥4.52 Billion | -3.54% |
| 2022-12-31 | CN¥4.69 Billion | +0.96% |
| 2021-12-31 | CN¥4.64 Billion | -6.76% |
| 2020-12-31 | CN¥4.98 Billion | +5.94% |
| 2019-12-31 | CN¥4.70 Billion | -21.66% |
| 2018-12-31 | CN¥6.00 Billion | +4.72% |
| 2017-12-31 | CN¥5.73 Billion | +7.98% |
| 2016-12-31 | CN¥5.30 Billion | +27.62% |
| 2015-12-31 | CN¥4.16 Billion | +223.25% |
| 2014-12-31 | CN¥1.29 Billion | +16.13% |
| 2013-12-31 | CN¥1.11 Billion | +23.70% |
| 2012-12-31 | CN¥894.89 Million | +1.71% |
| 2011-12-31 | CN¥879.82 Million | -2.52% |
| 2010-12-31 | CN¥902.60 Million | +3.84% |
| 2009-12-31 | CN¥869.23 Million | +7.10% |
| 2008-12-31 | CN¥811.59 Million | +0.27% |
| 2007-12-31 | CN¥809.43 Million | +1.70% |
| 2006-12-31 | CN¥795.90 Million | -28.09% |
| 2005-12-31 | CN¥1.11 Billion | +1.44% |
| 2004-12-31 | CN¥1.09 Billion | -24.28% |
| 2003-12-31 | CN¥1.44 Billion | -5.87% |
| 2002-12-31 | CN¥1.53 Billion | +4.20% |
| 2001-12-31 | CN¥1.47 Billion | -34.93% |
| 2000-12-31 | CN¥2.26 Billion | +69.36% |
| 1999-12-31 | CN¥1.33 Billion | +44.37% |
| 1998-12-31 | CN¥923.40 Million | +18.64% |
| 1997-12-31 | CN¥778.32 Million | +120.47% |
| 1996-12-31 | CN¥353.02 Million | +21.48% |
| 1995-12-31 | CN¥290.59 Million | +24.44% |
| 1994-12-31 | CN¥233.52 Million | -- |